OCTACELL 30 mg

Description

Composition: Octreotide 30 mg

Description: Octacell 30 mg (Octreotide Long Acting Release) Injection is a synthetic somatostatin used to inhibit the effects of certain hormones such as growth hormone.

Clinically proven in:

• Acromegaly
• Carcinoid tumours
• Bleeding oesophagal varices

Category segment: Somatostatin analogue for Oncology & Surgery

Therapeutic class: Prevents aberrant tissue growth and problems after pancreatic surgery